Ashley Groters
Nurse Practitioner · Gaylord, MINPI 1225660285
Payments from drug & device makers
Across 92 payments — averaging $16.58 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$287
- AstraZeneca$250
- Novo Nordisk$237
- Lilly USA, LLC$129
- Amgen$115
- Pfizer$107
- plus $401 from 12 others
What the payments were for
- Food & beverage$1,51199%
- Education$141%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 16 | $287 |
| AstraZeneca | 16 | $250 |
| Novo Nordisk | 16 | $237 |
| Lilly USA, LLC | 9 | $129 |
| Amgen | 7 | $115 |
| Pfizer | 7 | $107 |
| Boehringer Ingelheim | 4 | $83 |
| GSK | 3 | $74 |
| Otsuka America Pharmaceutical, Inc. | 3 | $65 |
| Bayer | 2 | $34 |
| E.r. Squibb & Sons, L.L.C. | 2 | $26 |
| Medtronic | 1 | $20 |
| Exact Sciences | 1 | $19 |
| Dexcom, Inc. | 1 | $19 |
| Organon | 1 | $18 |
| Merck | 1 | $18 |
| Teva Pharmaceuticals USA, Inc. | 1 | $12 |
| Kowa Pharmaceuticals America, Inc. | 1 | $11 |
How this compares
$1,525 in reported general payments places this provider in the 85th percentile of 3,351 nurse practitioner providers in Michigan.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MounjaroTirzepatide | 38 | $38,147 |
| EliquisApixaban | 30 | $22,764 |
| FarxigaDapagliflozin Propanediol | 14 | $20,824 |
| JardianceEmpagliflozin | 13 | $14,117 |
| Spiriva RespimatTiotropium Bromide | 13 | $6,682 |
| Fluticasone-SalmeterolFluticasone Propion/Salmeterol | 15 | $2,859 |
| Atorvastatin Calcium | 170 | $2,430 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 20 | $1,715 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 40 | $1,305 |
| Levothyroxine Sodium | 103 | $1,290 |
| Ventolin HfaAlbuterol Sulfate | 20 | $1,206 |
| Ezetimibe | 27 | $1,174 |
| Omeprazole | 89 | $1,042 |
| Rosuvastatin Calcium | 56 | $832 |
| Losartan Potassium | 54 | $815 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCMounjaro | $129 | $38,14738 claims |
| PfizerEliquis | $107 | $22,76430 claims |
| AstraZenecaFarxiga | $250 | $20,82414 claims |
| Boehringer IngelheimJardiance, Spiriva Respimat | $83 | $20,79926 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 3,351 nurse practitioner providers in Michigan.
Other nurse practitioner in Gaylord
- Davida KrugerDetroit$1.8M
- Kari HillSpring Lake$426K
- Kyle FarrPlymouth$243K
- Linda SpencerTroy$217K
- Ellen DillardDetroit$168K
- Golbon AghamohammadiDetroit$157K
- Abubakir BabanDearborn$143K
- Elizabeth KirshnerAnn Arbor$119K
- Lisa Astalos ChismWoodhaven$103K
- Martha GoetzPetoskey$101K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.